Perk Pharmaceuticals Ltd
Perk Pharmaceuticals Ltd (530673): company summary
Perk Pharmaceuticals Ltd (530673) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
Perk Pharmaceuticals Ltd (530673) is an Indian listed company operating in Pharmaceuticals & Biotechnology on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -2.4% a year over three years. Return on equity is 1.2%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Held back by risk (0.0). The latest financials on file are more than 18 months old, so treat the fundamental measures with caution. Scored on 3 of 5 measures.
DocStoX score
Low confidenceScored on 3 of 5 measures — the rest have no data for this company.
At a glance
Key highlights
- Growth is weak (0.5/10)
- Risk is weak (0.0/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals & Biotechnology
Explore Perk Pharmaceuticals Ltd’s valuation
Free deep-dive tools · no sign-up
Perk Pharmaceuticals Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Perk Pharmaceuticals Ltd with peers
Related tools & concepts
Value Perk Pharmaceuticals Ltd with the ratios and calculators DocStoX uses in its analysis.

